PO10-TU-33 Development of a new formulation of subcutaneous interferon beta-1a for relapsing-remitting multiple sclerosis: efficacy, safety and immunogenicity results from a comprehensive pre-clinical and clinical trial series

✍ Scribed by G. Giovannoni; N. De Stefano; M. Migliaccio

• Book ID: 119468131
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 47 KB
• Volume: 285
• Category: Article
• ISSN: 0022-510X
• DOI: 10.1016/s0022-510x(09)70782-8